Status:

COMPLETED

A Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue Biopsy

Lead Sponsor:

National Institutes of Health Clinical Center (CC)

Conditions:

Lung Neoplasms

Liver Neoplasms

Eligibility:

All Genders

18+ years

Phase:

PHASE1

Brief Summary

Background: \- Currently, standard procedures for biopsies that are guided by computed tomography (CT) imaging involve CT scans and a computer program to plan and illustrate where the physician will ...

Detailed Description

Background: * Currently, standard/conventional CT-guided biopsies proceed as follows the physician: 1. obtains a pre-procedural CT scan, 2. plans the needle s angle based on this CT scan, 3. s...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • Patients must fulfill all of the following criteria to be eligible for study admission:
  • All patients must be undergoing a CT-guided biopsy.
  • Age greater than 18 years.
  • No serious concurrent medical illness that would preclude the patient from making a rational informed decision on participation.
  • The ability to understand and willingness to sign a written informed consent form, and to comply with the protocol. If in question, an ethics consult will be obtained.
  • Ability to follow breathing instructions like holding breath (if procedure is to be performed without general anesthesia).
  • Patients must be actively enrolled on an NIH protocol and be scheduled for a CT-guided biopsy.
  • EXCLUSION CRITERIA:
  • Patients with an altered mental status that precludes understanding or consenting for the biopsy procedure will be excluded from this study.
  • Patients unlikely to be able to hold reasonably still on a procedure table for the length of the procedure.
  • Patients with any known allergy to plastics or polymers (since the Ultem -polymer could theoretically induce a rash in these patients, even though it is hypoallergenic).
  • Inability to follow breathing instructions, if without general anesthesia.
  • Patients with pacemakers or automatic implantable cardiac defibrillators.
  • Gross body weight above the CT table limit (450 pounds).

Exclusion

    Key Trial Info

    Start Date :

    March 20 2012

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    November 16 2016

    Estimated Enrollment :

    17 Patients enrolled

    Trial Details

    Trial ID

    NCT01218854

    Start Date

    March 20 2012

    End Date

    November 16 2016

    Last Update

    September 22 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    National Institutes of Health Clinical Center

    Bethesda, Maryland, United States, 20892